Cargando…
Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis
BACKGROUND: Metanephric neoplasms comprised a spectrum of kidney tumors containing renal epithelial or stromal cells or both, including metanephric adenoma, metanephric stromal tumor, and metanephric adenofibroma. The majority of cases were benign; only one case of “metanephric adenosarcoma” had bee...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193982/ https://www.ncbi.nlm.nih.gov/pubmed/25267074 http://dx.doi.org/10.1186/s13000-014-0179-7 |
_version_ | 1782339063837097984 |
---|---|
author | Su, Tiefen Yan, Fei Zhu, Pengcheng |
author_facet | Su, Tiefen Yan, Fei Zhu, Pengcheng |
author_sort | Su, Tiefen |
collection | PubMed |
description | BACKGROUND: Metanephric neoplasms comprised a spectrum of kidney tumors containing renal epithelial or stromal cells or both, including metanephric adenoma, metanephric stromal tumor, and metanephric adenofibroma. The majority of cases were benign; only one case of “metanephric adenosarcoma” had been reported in the English literature. HISTORY: We present the case of a 69-year-old man who developed a neoplasm composed of renal epithelial component identical to metanephric adenoma combined with malignant spindle-cell stroma. The epithelial component was positive for CD57, AE1/AE3, but negative for WT-1, CD56, SYN, and CgA; whereas the sarcomatous component was negative for epithelial markers, SMA, Caldesmon, MyoD1, Myogenin, and S-100; and positive for vimentin, CD10, and WT1 focally. No specific sarcoma differentiation was apparent in the stroma by immunohistochemistry, and no SYT-SS18 rearrangement or BRAF mutation was detected by molecular analysis. A diagnosis of metanephric adenosarcoma was made because of the morphological features and immunohitochemistry and molecular pathology analysis. CLINICAL SIGNIFICANCE: We believe that metanephric adenosarcoma should be in the expanded spectrum of metanephric neoplasia as a malignant stromal variant. CONCLUSIONS: We report a rare case of metanephric adenosarcoma with immunohistochemistry and molecular analysis and emphasize the histopathologic features and differential diagnosis of the rare lesion to promote a better and broader understanding of this less understood subject. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_179 |
format | Online Article Text |
id | pubmed-4193982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41939822014-10-12 Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis Su, Tiefen Yan, Fei Zhu, Pengcheng Diagn Pathol Case Report BACKGROUND: Metanephric neoplasms comprised a spectrum of kidney tumors containing renal epithelial or stromal cells or both, including metanephric adenoma, metanephric stromal tumor, and metanephric adenofibroma. The majority of cases were benign; only one case of “metanephric adenosarcoma” had been reported in the English literature. HISTORY: We present the case of a 69-year-old man who developed a neoplasm composed of renal epithelial component identical to metanephric adenoma combined with malignant spindle-cell stroma. The epithelial component was positive for CD57, AE1/AE3, but negative for WT-1, CD56, SYN, and CgA; whereas the sarcomatous component was negative for epithelial markers, SMA, Caldesmon, MyoD1, Myogenin, and S-100; and positive for vimentin, CD10, and WT1 focally. No specific sarcoma differentiation was apparent in the stroma by immunohistochemistry, and no SYT-SS18 rearrangement or BRAF mutation was detected by molecular analysis. A diagnosis of metanephric adenosarcoma was made because of the morphological features and immunohitochemistry and molecular pathology analysis. CLINICAL SIGNIFICANCE: We believe that metanephric adenosarcoma should be in the expanded spectrum of metanephric neoplasia as a malignant stromal variant. CONCLUSIONS: We report a rare case of metanephric adenosarcoma with immunohistochemistry and molecular analysis and emphasize the histopathologic features and differential diagnosis of the rare lesion to promote a better and broader understanding of this less understood subject. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_179 BioMed Central 2014-09-30 /pmc/articles/PMC4193982/ /pubmed/25267074 http://dx.doi.org/10.1186/s13000-014-0179-7 Text en © Su et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Su, Tiefen Yan, Fei Zhu, Pengcheng Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title | Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title_full | Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title_fullStr | Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title_full_unstemmed | Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title_short | Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
title_sort | metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193982/ https://www.ncbi.nlm.nih.gov/pubmed/25267074 http://dx.doi.org/10.1186/s13000-014-0179-7 |
work_keys_str_mv | AT sutiefen metanephricadenosarcomaararecasewithimmunohistochemistryandmolecularanalysis AT yanfei metanephricadenosarcomaararecasewithimmunohistochemistryandmolecularanalysis AT zhupengcheng metanephricadenosarcomaararecasewithimmunohistochemistryandmolecularanalysis |